Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance

BACKGROUND: Tuberculosis (TB) is the world’s leading infectious cause of death. Extrapulmonary TB accounts for 15% of TB cases, but the proportion is increasing, and over half a million people were newly diagnosed with rifampicin‐resistant TB in 2016. Xpert(®) MTB/RIF (Xpert) is a World Health Organ...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohli, Mikashmi, Schiller, Ian, Dendukuri, Nandini, Dheda, Keertan, Denkinger, Claudia M, Schumacher, Samuel G, Steingart, Karen R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2018
Materias:
Medicine General & Introductory Medical Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513199/
https://www.ncbi.nlm.nih.gov/pubmed/30148542
http://dx.doi.org/10.1002/14651858.CD012768.pub2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513199/
https://www.ncbi.nlm.nih.gov/pubmed/30148542
http://dx.doi.org/10.1002/14651858.CD012768.pub2

Ejemplares similares